NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 10, 2025 |
|
| Provision for doubtful accounts | $ 16,430 | $ 29,711 | |
| Provision for doubtful accounts | 13,375 | ||
| Cash, uninsured amount | 3,793 | 10,075,162 | |
| Impairment of long-lived assets | 30,068,794 | 6,772,500 | |
| Company's contributions to the retirement plan | $ 508,947 | $ 535,475 | |
| Anti-dilutive securities | 0 | 0 | |
| Shandong Rngyuan Pharmaceutical Co., Ltd | |||
| Equity interest | 100.00% | ||
| Chemical Products | |||
| Approximate cost of relocation | $ 69,000,000 | ||
| Relocation costs | $ 45,584,344 | $ 45,584,344 | |
| X | ||||||||||
- Definition Rate of equity interest ownership. No definition available.
|
| X | ||||||||||
- Definition Property, plant and equipment, capitalized costs. No definition available.
|
| X | ||||||||||
- Definition Approximate costs of relocation process. No definition available.
|
| X | ||||||||||
- Definition Amount of allowance for credit loss on accounts receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Amount of contribution received by defined benefit plan from employer which increases plan assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|